Summit Therapeutics (SMMT) EBITDA Margin (2017 - 2022)
Summit Therapeutics (SMMT) reported EBITDA Margin of -10046.24% for FY2022, down 5356.41 percentage points from -4689.83% in FY2021.
Powered by 
Analysis
Summit Therapeutics (SMMT) EBITDA Margin (2017 - 2022) Analysis & Trends
Dating back to FY2017, Summit Therapeutics' EBITDA Margin record includes 6 years.
- EBITDA Margin has a five-year change of -7787.82 percentage points (FY2017 to FY2022).
- The FY2022 figure ranks as the lowest annual EBITDA Margin since FY2019.
- According to Business Quant data, EBITDA Margin came in at -4689.83% in FY2021 (+1314.94 pp), -6004.77% in FY2020 (+5317.68 pp), -11322.44% in FY2019 and -121.37% in FY2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | 39.16% |
| 10 | Summit Therapeutics | 11.90 Bn | 9.66 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | -7,559.09% |
| Jun 30, 2022 | -5,260.00% |
| Mar 31, 2022 | -8,736.40% |
| Dec 31, 2021 | -10,246.61% |
| Sep 30, 2021 | -1,462.87% |
| Jun 30, 2021 | -41,022.81% |
| Mar 31, 2021 | -8,639.58% |
| Dec 31, 2020 | -5,998.92% |
| Sep 30, 2020 | -9,140.33% |
| Jun 30, 2020 | -8,841.76% |
| Mar 31, 2020 | -6,270.85% |
| Dec 31, 2019 | -18,541.67% |
| Oct 31, 2019 | -15,437.10% |
| Jul 31, 2019 | -12,887.30% |
| Mar 31, 2019 | -4,483.73% |
| Apr 30, 2018 | -519.85% |
| Jan 31, 2018 | -775.43% |
| Oct 31, 2017 | -553.04% |
| Jul 31, 2017 | -282.21% |
| Apr 30, 2017 | -763.02% |
API Access
Summit Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SMMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "SMMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SMMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();